Disorders of ejaculation

Journal of Endocrinological Investigation

Volumn 25, Issue 11, 2002, Pages 1006-1019

  Jannini, Emmanuele A ^a   Simonelli, C ^b   Lenzi, A ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anorgasmia; Delayed ejaculation; Medical sexology; Premature ejaculation; Retrograde ejaculation

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; BETHANECHOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; EPHEDRINE; FLUOXETINE; GANGLION BLOCKING AGENT; GUANETHIDINE; IMIPRAMINE; LIDOCAINE; MIDODRINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PAROXETINE; PHENELZINE; PHENOXYBENZAMINE; PRILOCAINE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ACCESSORY SEX GLAND; ANAMNESIS; ANEJACULATION; ANORGASMIA; ASPERMIA; BEHAVIOR THERAPY; BLADDER SPHINCTER; CLINICAL TRIAL; CONSTIPATION; DEFICIENT EJACULATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DYSPEPSIA; EJACULATION; EJACULATION DISORDER; FATIGUE; HEADACHE; HUMAN; IMPOTENCE; INSOMNIA; LIBIDO DISORDER; MALE; NAUSEA; ORGANIC BRAIN SYNDROME; ORGANIC IMPOTENCE; PATHOGENESIS; PREMATURE EJACULATION; PROSTATITIS; PSYCHOGENESIS; RETROGRADE EJACULATION; REVIEW; SIDE EFFECT; SPERM; SYMPATHETIC REFLEX; THORACOLUMBAR SPINE; URETHRA; URETHRA OBSTRUCTION; VERTIGO; XEROSTOMIA; YAWNING;

EID: 0036958894     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344077     Document Type: Review

References (138)

1. Grenier G., Byers E.S. Rapid ejaculation: A review of conceptual, etiological, and treatment issues. Arch. Sex. Behav. 1995, 24: 447-472.
2. Newman H.F., Reiss H., Northrup J.D. Physical basis of emission, ejaculation, and orgasm in the male. Urology 1991, 19: 341-350.
3. Koreman S.G. Sexual function and dysfunction. In: Wilson J.D., Foster D.W., Kronenberg H.M., Larsen P.R. (Eds.), William's Textbook of Endocrinology, ed. 9. Saunders Co., Philadelphia, 1998, p. 928.
4. Benson G.M. Erection, emission and ejaculation. In: Knobil E., Neill J.D. (Eds.), The Physiology of Reproduction. Raven Press, New York, 1994, p. 1489.
5. Kedia K., Marrland C. Effect of sympathectomy and drugs on ejaculation. In: Sciarra J.J., Markland C., Speidel J.J. (Eds.), Control of Male Infertility. Harper & Row Pub., New York, 1975, p. 240.
6. Lue T., Helstrom W., McAninch J.W., Tanagho E.A. Priapism: A refined approach to diagnosis and treatment. J. Urol. 1986, 136: 104-108.
7. Buffum J. Pharmacosexology update: Prescription drugs and sexual function. J. Psychoact. Drugs 1986, 18: 97-106.
8. Maggi M., Malozowski S., Kassis S., Guardabasso V., Roadbard D. Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens. Endocrinology 1987, 120: 986-994.
9. Peri A., Fantoni G., Granchi S., et al. Gene expression of endothelin-1, endothelin-converting enzyme-1, and endothelin receptors in human epididymis. J. Clin. Endocrinol. Metab. 1997, 82: 3797-3806.
10. Peri A., Fantoni G., Granchi S., et al. Endothelin-1 is synthesized and biologically active in human epididymis via a paracrine mode of action. Steroids 1998, 63: 294-298.
11. Mulryan K., Gitterman D.P., Lewis C.J., et al. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 2000, 403: 86-89.
12. Yang C.C., Bradley W.E. Somatic innervation of the human bulbocavernosus muscle. Clin. Neurophysiol. 1999, 110: 421-418.
13. Foreman M.M., Hall J.L., Lover R.L. The role of the 5-HT2 receptor in the regulation of sexual performance of male rats. Life Sci. 1989; 45: 1263-1270.
14. Marson L., McKenna K.E. Serotoninergic neurotoxic lesions facilitate male sexual reflexes. Pharmacol. Biochem. Behav. 1994, 47: 883-888.
15. Mc Intosh T.K., Barfield R.J. Brain monoaminergic control of male reproductive period. II. Dopamine and post-ejaculatory refractory period. Behavioural. Brain Res. 1984, 12: 267-273.
16. Heaton J.P. Central neuropharmacological agents and mechanisms in erectile dysfunction: The role of dopamine. Neurosci. Biobehav. Rev. 2000; 24: 561-569.
17. Yavetz H., Yogev L., Hauser R., Lessing J.B., Paz G., Homonnai Z.T. Retrograde ejaculation. Human. Reprod. 1994, 9: 381-386.
18. Verma A., Hirsch D.J., Glatt C.E., Ronnett G.V., Snyder S.H. Carbon monoxide: A putative neural messenger. Science 1993, 259: 381-384.
19. Burnett A.L., Johns D.G., Kriegsfeld L.J., et al. Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2. Nature Med. 1998, 4: 84-87.
20. Ho K.M., Ny L., McMurray G., Andersson K.E., Brading A.F., Noble J.G. Co-localization of carbon monoxide and nitric oxide synthesizing enzymes in the human urethral sphincter. J. Urol. 1999; 161: 1968-1972.
21. Burnett A.L. Nitric oxide synthase and heme oxygenase knockout mice - What have we learned? Int. J. Impot. Res. 2000, 12 (Suppl. 3) S42-s44.
22. Kriegsfeld L.J., Demas G.E., Huang P.L., Burnett A.L., Nelson R.J. Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-). Physiol. Behav. 1999, 67: 561-566.
23. Pierce R.V. Common Sense Medical Adviser. World Dispensary Printing office, Buffalo, N.Y., 1888.
24. Whitehead C.S., Hoff C.A. Ethical Sex Relations. Hertel Co., Chicago 1922.
25. Huhner M. Disorders of the Sexual Function in the Male and Female. F.A. Davis Co., Philadelphia, 1916.
26. Kinsey A.C., Pomeroy W.B., Martin C.E. Sexual Behavior in the Human Male. W.B. Saunders, Philadelphia, 1948.
27. Frank E., Anderson C., Rubinstein D. Frequency of sexual dysfunction in "normal" couples. N. Engl. J. Med. 1978, 299: 111-115.
28. Schein M., Zyzanski S.J., Levine S. et al. The frequency of sexual problems among family practice patients. Fam. Pract. Res. J. 1988, 7: 122-134.
29. Rowland D.L., Cooper S.E., Schneider M. Defining premature ejaculation for experimental and clinical investigations. Arch. Sex. Behav. 2001, 30: 235-253.
30. Cooper A., Magnus R. A clinical trial of the beta blocker propranolol in premature ejaculation. J. Psychosom. Res. 1984, 28: 331-336.
31. Spiess W.F., Geer J.H., O'Donohue W.T. Premature ejaculation: Investigation of factors in ejaculatory latency. J. Abnorm. Psychol. 1984, 93: 242-245.
32. Strassberg D.S., Mahoney J.M., Schaugaard M., Hale V.E. The role of anxiety in premature ejaculation: A psychophysiological model. Arch. Sex. Behav. 1990, 19: 251-258.
33. Shover L.R., Friedman J.M., Weiler S.J., Heiman J.R., Lo Piccolo J. Multiaxial problem-oriented system for sexual dysfunction. Arch. Gen. Psych. 1982, 39: 614-619.
34. Colpi G.M., Fanciullacci F., Beretta G., Negri L., Zanollo A. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia 1986, 18: 583-586.
35. Masters W.H., Johnson V.E. Human Sexual Inadequacy. Little, Brown & Co, Boston, 1970.
36. Kaplan H.S. The New Sex Therapy: Active Treatment of Sexual Dysfunction. Brunner/Mazel, New York, 1974.
37. Vandereycken W. Towards a better delineation of ejaculatory disorders. Acta Psychiat. Belg. 1986, 86: 57-63.
38. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, ed. 3. APA, Washington, DC, 1987.
39. Ellis H. Studies in the Psychology of Sex. Random House, New York, 1936.
40. Kaplan H.S. How to Overcome Premature Ejaculation. Brunner-Mazel, New York, 1989.
41. Hong J. Survival of the fastest: On the origins of premature ejaculation. J. Sex. Res. 1984, 20: 109-112.
42. Spiess W.F., Geer J.H., O'Donohue W.T. Premature ejaculation: Investigation of factors in ejaculatory latency. J. Abnorm. Psychol. 1984, 93: 242-245.
43. Strassberg D.S., Kelly M.P., Carroll C., Kircher J.C. The psychophysiological nature of premature ejaculation. Arch. Sex. Behav. 1987, 16: 327-336.
44. Cohen P.G. The association of premature ejaculation and hypogonadotropic hypogonadism. J. Sex. Marital Ther. 1997, 23: 208-211.
45. Pirke K.M., Kockott G., Aldenhoff J., Besinger U., Feil W. Pituitary gonadal system function in patients with erectile impotence and premature ejaculation. Arch. Sex. Behav. 1979, 8: 41-48.
46. Omu A.E., Al-Baader A.A., Dashti H., Oriowo M.A. Magnesium in human semen: Possible role in premature ejaculation. Arch. Androl. 2001, 46: 59-66.
47. Carani C., Zini D., Cavicchioli C., Grandi M., Della Casa L., Marrama P. Metabolic pathologies and sexual behaviours. Sex. Progr. 1984, 2: 83-84.
48. Jannini E.A., Ulisse S., D'Armiento M. Thyroid hormone and male gonadal function. Endocrine Rev. 1995, 16: 443-459.
49. Xin Z.C., Chung W.S., Choi Y.D., Seong D.H., Choi Y.J., Choi H.K. Penile sensitivity in patients with primary premature ejaculation. J. Urol. 1996, 156: 979-981.
50. Cold C.J., Van Howe R.S. Somatosensory evoked potentials in patients with primary premature ejaculation. J. Urol. 1998, 159: 2103-2104.
51. Colpi G.M., Fanciullacci F., Beretta G., Negri L., Zanollo A. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia 1986, 18: 583-586.
52. Ozcan C., Ozbek E., Soylu A., Yilmaz U., Guzelipek M., Balbay M. Auditory event-related potentials in patients with premature ejaculation. Urology 2001, 58: 1025-1029.
53. Boneff A.N. Topical treatment of chronic prostatitis and premature ejaculation. Int. Urol. Nephrol. 1972, 4: 183-186.
54. Screponi E., Carosa E., Di Stasi E., Pepe M., Carruba G., Jannini E.A. Prevalence of chronic prostatitis in men with premature ejaculation. Urology 2001, 58: 198-202.
55. Brown A.J. Ciprofloxacin as cure of premature ejaculation. J. Sex. Marital Ther. 2000, 26: 351-352.
56. Stanley E. Premature ejaculation. B.M.J. 1981, 282: 1521-1522.
57. Meares E.M., Stamey T.A. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest. Urol. 1968, 5: 492-518.
58. Semans J.H. Premature ejaculation: A new approach. Southern Med. J. 1955, 49: 353-358.
59. Masters W.H., Johnson V.E. Male sexual response. In: Human Sexual Response. Little & Brown, Boston, 1966, p. 171.
60. Seftel A.D., Althof S.E. Premature ejaculation. In: Mulcahy J.J. (Ed.), Diagnosis and Management of Male Sexual Dysfunction. Igaku-Shoin, New York, 1997, p. 196.
61. Hawton K., Catalan J. Prognostic factors in sex therapy. Behav. Res. Ther. 1986, 24: 377-385.
62. McCarthy B.W. Cognitive-behavioral strategies and techniques in the treatment of early ejaculation. In: Leiblum S.R., Rosen R.C. (Eds.), Principles and Practice of Sex Therapy - Update for the 1990s, ed. 2. Guilford Press, New York, 1989, p 141.
63. Bennett D.Y. Treatment of ejaculation praecox with monoamine-oxidase inhibitors. Lancet 1961, 1: 1309.
64. Goodman R.E. An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J. Int. Med. Res. 1980, 8: 53-59.
65. Haensel S.M., Rowland D.L., Kallan K.T.H.K., Slob A.K. Clomipramine and sexual function in men with premature ejaculation and controls. J. Urol. 1996, 156: 1310-1315.
66. Althof S.E., Levine S.B., Corty E.W., Risen C.B., Stern E.B., Kurit D.M. A double-blind cross-over trial of clomipramine for rapid ejaculation in 15 couples. J. Clin. Psychiatry 1995, 56: 402-407.
67. Strassberg D.S., De Gouveia Brazao C.A., Rowland D.L., Tan P., Slob A.K. Clomipramine in the treatment of rapid (premature) ejaculation. J. Sex. Marital Ther. 1999, 25: 89-101.
68. Kara H., Aydin S., Agargun M.Y., Odabas O., Yilmaz Y. The efficacy of fluoxetine in the treatment of premature ejaculation: A double-blind placebo controlled study. J. Urol. 1996, 156: 1631-1632.
69. Waldinger M.D., Hengeveld M.W., Zwinderman A.H. Paroxetine treatment of premature ejaculation: A double-blind, randomized, placebo-controlled study. Am. J. Psychiatry 1994, 151: 1377-1379.
70. Waldinger M.D., Hengeveld M.W., Zwinderman A.H. Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: A double-blins, randomized, dose response study. Br. J. Urol. 1997, 79: 592-595.
71. Kim S.C., Seo K.K. Efficacy and safety of fluoxetine, sertraline, and clomipramine in patients with premature ejaculation: A double-blind, placebo controlled study. J. Urol. 1998, 159: 425-427.
72. McMahon C.G. Treatment of premature ejaculation with sertraline hydrochloride. Int. J. Impot. Res. 1998, 10: 181-184.
73. McMahon C.G. Treatment of premature ejaculation with sertraline hydrochloride: A single-blind placebo controlled crossover study. J. Urol. 1998, 159: 1935-1938.
74. McMahon C.G., Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int. J. Impot. Res. 1999, 11: 241-245.
75. Waldinger M.D., Zwinderman A.H., Olivier B. Antidepressants and ejaculation: A double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J. Clin. Psychopharmacol. 2001, 21: 293-297.
76. Seo K.K., Kim S.C., Lee M.Y. Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: In vitro and in vivo studies. J. Urol. 2001, 165: 2110-2114.
77. Rosen R.C., Lane R.M., Menza M. Effects of SSRIs on sexual function: A critical review. J. Clin. Psychopharmacol. 1999, 19: 67-85.
78. McMahon C.G., Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int. J. Impot. Res. 1999, 11: 141-145.
79. McMahon C.G., Touma K. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J. Urol. 1999, 161: 1826-1830.
80. Kim S.W., Paick J.S. Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology 1999, 54: 544-547.
81. Rowland D.L., De Gouveia Brazao C.A., Slob A. Effective daily treatment with clomipramine in men with premature ejaculation when 25 mg (as required) is ineffective. Br. J. Urol. Int. 2001, 87: 357-360.
82. Berman J., Berman L. For women only. Virago Press, London, 2001.
83. Abdel-Hamid I.A., El Naggar E.A., El Gilany A.H. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int. J. Impot. Res. 2001, 13: 41-45.
84. Montorsi F., Salonia A., Zanoni M. et al. Premature ejaculation: A prospective study comparing paroxetine alone vs paroxetine plus sildenafil. Preliminary results. Int. J. Impot. Res. 2001, 13 (Suppl. 4): 132 (Abstract).
85. Hsieh J.T., Liu S.P., Hsieh C.H., Cheng J.T. An in vivo evaluation of the therapeutic potential of sympatholytic agents on premature ejaculation. Br. J. Urol. Int. 1999, 84: 503-506.
86. Shilon M., Paz G.F., Homonnai Z.T. The use of phenoxybenzamine treatment in premature ejaculation. Fertil. Steril. 1984, 42: 659-661.
87. Beretta G., Chelo E., Fanciullacci F., Zanollo A. Effect of an alpha-blocking agent (phenoxybenzamine) in the management of premature ejaculation. Acta Eur. Fertil. 1986, 17: 43-45.
88. Berkovitch M., Keresteci A.G., Koren G. Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J. Urol. 1995, 154: 1360-1361.
89. Choi H.K., Xin Z.C., Choi Y.D., Lee W.H., Mah S.Y., Kim D.K. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int. J. Impot. Res. 1999, 11: 261-264.
90. Choi H.K., Jung G.W., Moon K.H. et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000, 55: 257-261.
91. Morales A. Developmental status of topical therapies for erectile and ejaculatory dysfunction. Int. J. Impot. Res. 2000, 4: 80-85.
92. Metz M.E., Pryor J.L. Premature ejaculation: A psychophysiological approach for assessment and management. J. Sex. Marital Ther. 2000, 26: 293-320.
93. Polonsky D.C. Premature ejaculation. In: Leiblum S.R., Rosen R.C. (Eds.), Principles and Practice of Sex Therapy, ed. 3. Guilford Press, New York, 2000, p. 305.
94. Apfelbaum B. Retarded ejaculation. A much misunderstood syndrome. In: Leiblum S.R., Rosen R.C. (Eds.), Principles and Practice of Sex Therapy, ed. 3. Guilford Press, New York, 2000, p. 205.
95. Wein A.J., Van Arsdale K.N. Drug-induced male sexual dysfunction. Urol. Clin. North Am. 1988, 15: 23-31.
96. Buffum J. Pharmacosexology: The effects of drugs on sexual function - A review. J. Psychoactive Drugs 1982, 14: 5-44.
97. Monteiro WO., Noshirvani H.F., Marks I.M., Lelliott P.T. Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. Br. J. Psychiatry 1987, 151: 107-112.
98. Segraves R.T. Effects of psychotropic drugs on human erection and ejaculation. Arch. Gen. Psychiatry 1989, 46: 275-284.
99. Harrison W.M., Rabkin J.G., Ehrhardt A.A. et al. Effects of antidepressant medication on sexual function: A controlled study. J. Clin. Psychopharmacol. 1986, 6: 144-149.
100. Yager J. Bethanechol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol. J. Clin. Psychiatry 1986, 47: 210-211.
101. Mitchell J.E., Popkin M.K. Antipsychotic drug therapy and sexual dysfunction in men. Am. J. Psychiatry 1982, 139: 633-637.
102. Kinsey A.C., Pomeroy W.B., Martin C.E. Sexual Behavior in Human Male. W.B. Saunders, Philadelphia, 1948.
103. Geboes K., Steeno O., De Moor P. Primary anejaculation: Diagnosis and therapy. Fertil. Steril. 1975, 26: 1018-1020.
104. Nehra A., Werner M.A., Bastuba M., Title C., Oates R.D. Vibratory stimulation and rectal probe electro-ejaculation as therapy for patients with spinal cord injury: Semen parameters and pregnancy rates. J. Urol. 1996, 155: 554-559.
105. Bors E., Comarr A.E. Neurological disturbances of sexual function with special reference to 529 patients with spinal cord injury. Urol. Surv. 1960, 10: 191-195.
106. Howards S.S. Treatment of male infertility. N. Engl. J. Med. 1995, 2: 312-317.
107. Riley A.J., Riley E.J. Partial ejaculatory incompetence: The therapeutic effect of midodrine, an orally active selective α-receptor agonist. Eur. Urol. 1982, 8: 155-160.
108. Brackett N.L., Ferrell S.M., Aballa T.C. et al. An analysis of 653 trials of penile vibratory stimulation in men with spinal cord injury. J. Urol. 1998, 159: 1931-1934.
109. Brackett N.L., Lynne C.M., Weizman M.S., Bloch W.E., Abae M. Endocrine profiles and semen quality of spinal cord injured men. J. Urol. 1994, 151: 114-119.
110. Sonksen J., Ohl D.A., Giwercman A., Biering-Sorensen F., Skakkebaek N.E., Kristensen J.K. Effect of repeated ejaculation on semen quality in spinal cord injured men. J. Urol. 1999, 161: 1163-1165.
111. Biering-Sorensen F., Sonksen J. Sexual function in spinal cord lesioned men. Spinal Cord 2001, 39: 455-470.
112. Hovav Y., Shotland Y., Yaffe H., Almagor M. Electroejaculation and assisted fertility in men with psychogenic anejaculation. Fertil. Steril. 1996, 66: 620-623.
113. Shatte E.C., Orejula F.J., Lipshultz L.I., Kim E.D., Lamb D.J. Treatment of infertility due to anejaculation in the male with electroejaculation and intracytoplasmic sperm injection. Urology 2000, 163: 1717-1720.
114. Fahmy I., Kamal A., Metwali M. et al. Vigorous prostatic massage: A simple method to retrieve spermatozoa for intracytoplasmic sperm injection in psychogenic anejaculation. Hum. Reprod. 1999, 14: 2050-2053.
115. Hovav Y., Kafka I., Horenstein E., Yaffe H. Prostatic massage as a method for obtaining spermatozoa in men with psychogenic anejaculation. Fertil. Steril. 2000, 74: 184-185.
116. Williams W. Anaesthetic ejaculation. J. Sex. Marital Ther. 1985; 11: 19-29.
117. Buffum J. Prescription drugs and sexual function. Psychiatr. Med. 1992, 10: 181-198.
118. Newman H. Reiss H., Northup J. Physical basis of emission, ejaculation, and orgasm in the male. Urology 1982, 4: 341-350.
119. Glezerman M., Lunenfeld B., Potashnik G., Oelsner G., Beer R. Retrograde ejaculation: Pathophysiologic aspects and report of two successfully treated cases. Fertil. Steril. 1976; 27: 796-800.
120. Lee S.S., Sun G.H., Yu D.S., Chen H.I., Chang S.Y. Giant hydronephrosis of a duplex system associated with ureteral ectopia: A cause of retrograde ejaculation. Arch. Androl. 2000, 45: 19-23.
121. Virupannavar C., Tomera F. An unusual case of retrograde ejaculation and a brief review of management. Fertil. Steril. 1982, 37: 275-276.
122. Strachan J.R., Heaton J.M., Pryor J.P. Retrograde ejaculation owing to ectopic erectile tissue. J. Urol. 1988, 139: 592-593.
123. Malone P.R., Cook A., Edmonson R., Gill M.W., Shearer R.J. Prostatectomy: Patients' perception and long-term follow-up. Br. J. Urol. 1988; 61: 234-238.
124. Jeffries J.J., Vanderhaeghe L., Remington G.J., Al-Jeshi A. Clozapine-associated retrograde ejaculation. Can. J. Psychiatry 1996, 41: 62-63.
125. Shiloh R., Weizman A., Weizer N., Dorfman-Etrog P., Munitz H. Risperidone-induced retrograde ejaculation. Am. J. Psychiatry 2001, 158: 650.
126. Debruyne F.M., Van Der Poel H.G. Clinical experience in Europe with uroselective alpha1-antagonists. Eur. Urol. 1999, 36 (Suppl. 1): 54-58.
127. Debruyne F.M. Alpha blockers: Are all created equal. Urology 2000, 56 (Suppl. 1): 20-22.
128. Anadalaro V.A., Dube A. Treatment of retrograde ejaculation with brompheniramine. Urology 1975, 5: 520-522.
129. Stewart B.H., Bergant J.A. Correction of retrograde ejaculation by sympathomimetic medication: Preliminary report. Fertil. Steril. 1974, 25: 1073-1074.
130. Sandler B. Idiopathic retrograde ejaculation. Fertil. Steril. 1979; 32: 474-475.
131. Jonas D., Linzbach P., Weber W. The use of midodrine in the treatment of ejaculation disorders following retroperitoneal lymphadenectomy. Eur. Urol. 1979; 5: 184-187.
132. Ochsenkuhn R., Kamischeke A., Nieschlag E. Imipramine for successful treatment of retrograde ejaculation caused by retroperitoneal surgery. Int. J. Androl. 1999, 22: 173-177.
133. Kamischke A., Nieschlag E. Treatment of retrograde ejaculation and anejaculation. Hum. Reprod. Update 1999, 5: 448-474.
134. Fairburn C.G., McCulloch D.K., Wu F.C. The effect of diabetes on male sexual, function. Clin. Endocrinol. Metab. 1982, 11: 749-767.
135. Thomas A.J. Ejaculatory dysfunction. Fertil. Steril. 1983, 39: 445-454.
136. Dunsmuir W.D., Holmes S.A.V. The aetiology and management of erectile, ejaculatory, and fertility problems in men with diabetes mellitus. Diabet. Med. 1996, 13: 700-708.
137. Shill W.B. Pregnancy after bromopheniramine treatment of diabetic with incomplete emission failure. Arch. Androl. 1990, 25: 101-104.
138. Wang R., Monga M., Hellstrom W.J.G. Ejaculatory dysfunction. In: Comhaire F.H. (Ed), Male Infertility: Clinical Investigation, Cause Evaluation and Treatment. Chapman and Hall, London, 1996, p. 205.